In Brief: Abbott Sales Down, Herbalife Investigated, GMO Labeling Legislation, NAD Reviews, FDA Warning Letters
This article was originally published in The Tan Sheet
Executive Summary
Abbott’s sales down; Herbalife investigated; National GMO labeling bill introduced; NAD cautions about implied comparative claims; Supplements cannot be topical; and Undeclared ingredients trigger warning.